6 References [1] C. A. Combs, E. L. Murphy, and R. K. Laros Jr., “Prolonged third stage of labor: morbidity and risk factors,” Obstetrics and Gynecology, vol. 77, no. 6, pp. 863–867, 1991. [2] M. P. Dombrowski, S. F. Bottoms, A. A. Aziz Saleh, W. W. Hurd, and R. Romero, “Third stage of labor: analysis of dura- tion and clinical practice,” American Journal of Obstetrics and Gynecology, vol. 172, no. 4 I, pp. 1279–1284, 1995. [3] A. Herman, Z. Weinraub, I. Bukovsky et al., “Dynamic ultrasonographic imaging of the third stage of labor: new per- spectives into third-stage mechanisms,” American Journal of Obstetrics and Gynecology, vol. 168, no. 5, pp. 1496–1499, 1993. [4] A. M. G u¨lmezoglu and World Health Organization, WHO Guidelines for the Management of Postpartum Hemorrhage and Retained Placenta, World Health Organization, Geneva, Switzerland, 2009. [5] A. D. Weeks, G. Alia, G. Vernon et al., “Umbilical vein oxy- tocin for the treatment of retained placenta (release study): a double-blind, randomised controlled trial,” The Lancet, vol. 375, no. 9709, pp. 141–147, 2010. [6] M. Bullarbo, J. Tjugum, and E. Ekerhovd, “Sublingual nitro- glycerin for management of retained placenta,” International Journal of Gynecology and Obstetrics, vol. 91, no. 3, pp. 228– 232, 2005. [7] E. Ekerhovd and M. Bullarbo, “Sublingual nitroglycerin seems to be eﬀective in the management of retained placenta,” Acta Obstetricia et Gynecologica Scandinavica, vol. 87, no. 2, pp. 222–225, 2008. [8] E. Chandraharan and S. Srulkumaran, “Acute tocolysis,” Current Opinion in Obstetrics and Gynecology, vol. 17, no. 2, pp. 151–156, 2005. [9] H. Abdel-Aleem, M. A. Abdel-Aleem, and O. M. Shaaban, “Tocolysis for management of retained placenta,” Cochrane Database of Systematic Reviews, vol. 1, Article ID CD007708, 2011. [10] A. T. C. Peng, R. S. Gorman, S. M. Shulman, E. DeMarchis, K. Nyunt, and L. S. Blancato, “Intravenous nitroglycerin for uterine relaxation in the postpartum patient with retained placenta,” Anesthesiology, vol. 71, no. 1, pp. 172–173, 1989. [11] C. A. DeSimone, M. C. Norris, and B. L. Leighton, “Intra- venous nitroglycerin aids manual extraction of a retained placenta,” Anesthesiology, vol. 73, no. 4, article 787, 1990. [12] I. P. Lowenwirt, R. M. Zauk, and S. M. Handwerker, “Safety of intravenous glyceryl trinitrate in management of retained placenta,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 37, no. 1, pp. 20–24, 1997. [13] P. Axemo, X. Fu, B. Lindberg, U. Ulmsten, and A. Wessen, “Intravenous nitroglycerin for rapid uterine relaxation,” Acta Obstetricia et Gynecologica Scandinavica, vol. 77, no. 1, pp. 50– 53, 1998. [14] P. A. Chedraui and D. F. Insuasti, “Intravenous nitroglycerin in the management of retained placenta,” Gynecologic and Obstetric Investigation, vol. 56, no. 2, pp. 61–64, 2003. [15] A. D. Weeks, “The retained placenta,” Best Practice and Research, vol. 22, no. 6, pp. 1103–1117, 2008. Obstetrics and Gynecology International